HM Payson & Co’s iShares Biotechnology ETF IBB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | $31.3K | Sell |
245
-636
| -72% | -$81.3K | ﹤0.01% | 718 |
|
|
2024
Q4 | $116K | Hold |
881
| – | – | ﹤0.01% | 513 |
|
|
2024
Q3 | $128K | Sell |
881
-328
| -27% | -$47.8K | ﹤0.01% | 490 |
|
|
2024
Q2 | $166K | Sell |
1,209
-1
| -0.1% | -$137 | ﹤0.01% | 428 |
|
|
2024
Q1 | $166K | Hold |
1,210
| – | – | ﹤0.01% | 434 |
|
|
2023
Q4 | $164K | Sell |
1,210
-140
| -10% | -$19K | ﹤0.01% | 417 |
|
|
2023
Q3 | $165K | Sell |
1,350
-25
| -2% | -$3.06K | ﹤0.01% | 408 |
|
|
2023
Q2 | $175K | Hold |
1,375
| – | – | ﹤0.01% | 391 |
|
|
2023
Q1 | $178K | Hold |
1,375
| – | – | ﹤0.01% | 389 |
|
|
2022
Q4 | $180K | Sell |
1,375
-27
| -2% | -$3.54K | ﹤0.01% | 386 |
|
|
2022
Q3 | $164K | Hold |
1,402
| – | – | ﹤0.01% | 402 |
|
|
2022
Q2 | $165K | Sell |
1,402
-9
| -0.6% | -$1.06K | ﹤0.01% | 406 |
|
|
2022
Q1 | $184K | Buy |
1,411
+176
| +14% | +$23K | ﹤0.01% | 413 |
|
|
2021
Q4 | $188K | Buy |
1,235
+1,002
| +430% | +$153K | ﹤0.01% | 409 |
|
|
2021
Q3 | $38K | Hold |
233
| – | – | ﹤0.01% | 636 |
|
|
2021
Q2 | $38K | Buy |
233
+8
| +4% | +$1.31K | ﹤0.01% | 636 |
|
|
2021
Q1 | $34K | Hold |
225
| – | – | ﹤0.01% | 676 |
|
|
2020
Q4 | $34K | Hold |
225
| – | – | ﹤0.01% | 681 |
|
|
2020
Q3 | $30K | Hold |
225
| – | – | ﹤0.01% | 657 |
|
|
2020
Q2 | $31K | Sell |
225
-30
| -12% | -$4.13K | ﹤0.01% | 594 |
|
|
2020
Q1 | $27K | Sell |
255
-102
| -29% | -$10.8K | ﹤0.01% | 589 |
|
|
2019
Q4 | $43K | Buy |
357
+30
| +9% | +$3.61K | ﹤0.01% | 610 |
|
|
2019
Q3 | $33K | Hold |
327
| – | – | ﹤0.01% | 654 |
|
|
2019
Q2 | $36K | Buy |
+327
| New | +$36K | ﹤0.01% | 652 |
|